JALGX | JQLGX | JALGX / JQLGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 19 years | 13 years | - |
Gain YTD | 2.833 | 2.869 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.56B | 8.56B | 100% |
Annual Yield % from dividends | 1.60 | 1.55 | 103% |
Returns for 1 year | 10.90 | 10.87 | 100% |
Returns for 3 years | -1.07 | -1.42 | 75% |
Returns for 5 years | 8.10 | 7.44 | 109% |
Returns for 10 years | -1.08 | -2.27 | 48% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SEMNX | 17.54 | -0.05 | -0.28% |
Hartford Schroders Emerging Mkts Eq I | |||
PJHRX | 32.31 | -0.18 | -0.55% |
PGIM Jennison Health Sciences R | |||
AAIPX | 16.16 | -0.10 | -0.62% |
American Beacon International Eq Inv | |||
AMRBX | 4.70 | -0.07 | -1.47% |
American Growth One B | |||
DAFGX | 39.08 | -0.86 | -2.15% |
Dunham Focused Large Cap Growth A |